FRANKLIN, Wis., May 2, 2013 /PRNewswire/ -- Great Lakes Dermatology is bringing a night of anti-aging and beauty to patients and consumers: Announcing the second annual "Look Great. Feel Great" open house, held from 6 to 8 p.m. on Thursday, May 2 at the Franklin Clinic, located at 10500 W. Loomis Road in Franklin, Wisconsin.

"Look Great. Feel Great" will feature top-notch, popular treatments offered by the practice, including live demonstrations for sclerotherapy, laser treatments, chemical peels, injectables such as Botox and Juvederm and color matching. Great Lakes Dermatology is also pleased to welcome special guest Miss Wisconsin USA, Chrissy Zamora. She will be available to sign pictures and speak on the importance of empowering women through self-confidence.

In addition, Great Lakes Dermatology will unveil its line-up of exciting new procedures now available to patients. From the company that brought you the revolutionary Pellev Wrinkle Reduction System, Ellman International, are three new laser systems providing treatments that boast impressive results, minimum discomfort and virtually no downtime:

Cortex: A versatile laser skin resurfacing system that provides two wavelengths that address lines and wrinkles: C02 for deep, effective resurfacing and Erbium YAG for superficial resurfacing, an effective alternative to peels.

Apex: A system with two technologies rolled into one: the IPL application helps treat acne, uneven pigmentation, vascular lesions, reduces hair and sun-damaged skin with minimal discomfort and no downtime and the Erbium YAG application is ideal for treating superficial resurfacing and smoothing fine lines and wrinkles, including hard-to-treat areas such as around the eyes and backs of hands.

Cheveux: A favorite of Great Lakes technicians, the Cheveux is a permanent hair reduction solution for face and body. It utilizes Smooth Flow 10P Technology to deliver rapid pulses of energy and has cooling features for a more comfortable treatment.

"These powerful lasers are the best and most effective lasers that the industry has to offer. Our patients told us what they wanted an affordable anti-aging laser treatment and the Cortex, Apex, and Cheveux devices matched those needs," commented Teigan Canella, Cosmetic and Aesthetics Manager.

"Patients are pleasantly surprised by the vast number of conditions these lasers can treat. In fact, we are so thrilled to offer these new treatments that we're confident they will change the way our patients age and feel about their skin, often improving areas of their body that they're unhappy or insecure about," Canella continues.

In addition, the "Look Great. Feel Great" event will also offer complimentary skin cancer screenings and information from forward-thinking companies focused on anti-aging: NeoStrata, Allergan, Merz Aesthetics, Franklin Dental and Innovative Health and Fitness. Dr. Paul Cimoch can answer attendee's questions about anti-aging medicine and skin rejuvenation.

About Great Lakes Dermatology With 11 locations currently serving southeastern Wisconsin, Great Lakes Dermatology thrives on their practice philosophy "Your kind of skin care." In total, the locations serve tens of thousands of patients in both medical treatments and cosmetic services, with each specialist striving to provide the best patient experience in an inviting and comfortable environment.

See the article here:
Great Lakes Dermatology Expanding Portfolio of Anti-Aging Procedures with New Cortex, Apex and Cheveux Laser Devices

WEST ORANGE, N.J., April 29, 2013 /PRNewswire-iReach/ -- Dr. Dov Rand is proud to announce the introduction of multiple new services focused on improving the lives of his patients. Each new procedure and treatment is focused on transforming the health of women and men with diseases related to the aging process. The new procedures are a direct result of Dr. Dov Rand and his colleagues interest in functional medicine.

"Too often, western medicine focuses on the symptom and the symptom only. With functional medicine, we take a look at the patient as a whole. We want to treat the person and not just the problem they're seeking help for," says Dr. Dov Rand .

"We have launched programs specializing in different areas. Our new programs focus on weight loss, Yolo fat burning, and gut health programs. We also introduced programs for dysbiosis and food allergies," adds Dr. Dov Rand. Those were not the only programs introduced to Dr. Dov Rand 's medical office. Other programs recently introduced include bio-identical hormone replacement, vitamin therapy including IV vitamins, and Botox and fillers for facial rejuvenation.

"In all that we do, we focus on functional medicine. At the forefront of our practice is patient centered care. That is why we practice functional medicine. We've seen repeatedly how satisfied patients are with our practice. That is why I have personally received the Patient Recognition Award four consecutive years," says Dr. Dov Rand.

Patients seem to appreciate Dr. Dov Rand 's ability to restore balance to their lives and bodies. Many people notice differences about themselves as they age, and not all those differences are external. Dr. Dov Rand introduced all the new procedures to deal with imbalances or changes both internal and external. "Our treatments do work. I've treated several hundred patients and the results of treatment have been absolutely amazing," says Dr. Dov Rand .

Patients appreciate Dr. Dov Rand's ability to improve how they look and feel. If they want to restore a youthful appearance, they can choose Botox or another facial rejuvenation procedure. If they want to feel better, Dr. Dov Rand can help them determine what treatment they need.

About: Dr. Dov Rand introduced new procedures to improve patients' health inside and out.

Media Contact:

Dov Rand Optimizeup.com, 973-325-6400, support@optimizeup.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

Read more here:
Dr. Dov Rand Launches New Programs

Dr. Ed Park on why there may be no Maximum Lifespan - iHealthTube10
Dr. Park was Interviewed by iHealthTube #39;s Scott Peters at the 2012 A4M (American Academy of Anti-aging Medicine) Conference in Las Vegas. This is #10 of 10 s...

By: Ed Park

Read the original post:
Dr. Ed Park on why there may be no Maximum Lifespan - iHealthTube10 - Video

Dr. Ed Park on why TA-65 is better than HGH - iHealthTube 8
Dr. Park was Interviewed by iHealthTube #39;s Scott Peters at the 2012 A4M (American Academy of Anti-aging Medicine) Conference in Las Vegas. This is #8 of 10 se...

By: Ed Park

Read more from the original source:
Dr. Ed Park on why TA-65 is better than HGH - iHealthTube 8 - Video

A recently published Marie Claire magazine article highlights various foreign cosmetic markets and their approach to providing clear, even skin tone. Dr. Simon Ourian of Epione Beverly Hills says that the epitome of beauty is always changing and aesthetic practitioners must evolve to meet this challenge.

Los Angeles, California (PRWEB) April 19, 2013

According to the article, smooth skin with no wrinkles or crow's feet is always highly valued, but skin without blemishes and that absorbs light may be even more highly regarded. When one is young and skin is at its pinnacle of health, melanocyte cells within the outer dermis supply pigment to the skins surface providing an even tone. With aging this production decreases, so that the remaining pigment clusters up instead of spreading smoothly. The global beauty industry is banking on reversing this trend.

In our medical practice at Epione, Id say that the focus is on wrinkle correction and skin tightening though we also use laser treatments to address skin tone issues, says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. My over-the-counter Signature Series Restoration Firm & Lift Crme was specifically created to address skin tone and clarity.

The Marie Claire goes on to describe efforts around the world to meet the demand for flawless, bright skin:

In China, the trend is to use holistic medicine. A white rose known as rosa roxburhii grows in the Chinese mountains and is packed full of the anti-oxidants that reportedly combat skin aging by attacking blotchy complexions and evening coloration. The French are using sugar structures to boost the strength of skin cells that produce spots when they receive too much melanin. Vitamin C derivatives are said to help the skin reflect more light and appear to be glowing.

Israeli dermatologists have used a compound rich in melanozyme, an enzyme developed from tree fungal growths that keep facial skin from developing the dark spots that lead to discontinuity in tone. In Japan whitening cultures are used to actively keep dark spots from producing. Kojic acid, for example, eliminates free radicals that lead to melanin production.

The ideal of beauty is ever changing and may be different from place to place and country to country, concludes Dr. Ourian. Its my job as a cosmetic practitioner to meet the aesthetic goals of my patients.

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about the rising concern over skin tone can be found on Epiones website.

Grace Russell Epione Medical Corporation (888) 951-3377 Email Information

See the original post here:
Skin Tone – The Anti-Aging Market Focuses on Brighter Skin as the Epitome of Youth

LOS ANGELES, April 17, 2013 /PRNewswire-iReach/ --

Nationally known dermatologist, Dr. Heidi Gilchrist, has announced her endorsement of a Japanese anti aging beauty secret, that is new to America, called Beauty Nectar by the natural anti-aging company Ashieda.

(Photo: http://photos.prnewswire.com/prnh/20130417/CG96369)

Beauty Nectar, collagen drink, is a 100% natural beauty drink made of liquid collagen, antioxidants, ceramide, resveratrol and vitamin C. All the rage in Japan and the UK, Asheida is the first company to bring this convenient, great tasting, daily 2oz drink to the USA to help women prevent aging naturally. The results of this drink are nothing short of astounding and have been clinically proven. The main benefits are: hydrated skin, skin renewal, anti aging - reduced fine lines and wrinkles, even skin tone, brightened and glowing youthful appearance and firmer skin. Dr. Heidi Gilchrist has solid foundational training in conventional Western medicine, but she also embraces a holistic, integrated approach to skin health.

Ashieda is dedicated to providing women with anti aging products which are formulated from the world's most effective and natural ingredients. Ashieda prides themselves on their natural, world-class ingredients, ones proven to work.

Dr. Heidi Gilchrist and Ashieda complement each other well because both agree on a natural and holistic approach to effective anti aging.

For more information about Beauty Nectar by Ashieda, please visit http://ASHIEDA.com or call Sarah Ehrlich at 310-888-8601 for more information on Dr Heidi Gilchrist visit http://www.gilchristdermatology.com Media Contact:

Sarah Ehrlich Ashieda, 3108888601, sarah@ashieda.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

Read more here:
MD Endorses Latest US Anti Aging Beauty Secret

Dr. Ed Park explains TA-65 - iHealthTube6
Dr. Park was Interviewed by iHealthTube #39;s Scott Peters at the 2012 A4M (American Academy of Anti-aging Medicine) Conference in Las Vegas. This is #6 of 10 se...

By: Ed Park

Visit link:
Dr. Ed Park explains TA-65 - iHealthTube6 - Video

Cacao Based Anti-Aging
Xocai® has scientifically formulated the first-of-its- kind, cacao-based, anti-aging skin care product line. XoVitality trade; and Xophoria trade; unlock the natural ski...

By: Paul G Waring

Read more here:
Cacao Based Anti-Aging - Video

A recent article in New Beauty magazine highlights several recently introduced anti-aging innovations. Dr. Simon Ourian of Epione Beverly Hills says hed like to see more data showing the effectiveness of these devices.

Los Angeles, California (PRWEB) April 09, 2013

I like to think that I work on the cutting edge of aesthetic medicine, but in truth I will always wait for sufficient data to be collected before I introduce new devices or products to my patients, says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. The innovations discussed in the article are interesting but Im not ready to add them to my practice just yet.

Until now, dermal fillers have only been administered with needle injections. According to the manufacturers of a new device this makes the patient more susceptible to swelling and bruising. Using pressure driven by CO2 this device allows the doctor to easily control the flow of the treatment and more accurately place fillers.

Another new device on the market allows doctors to determine a patients skin type in order to gauge how they will respond to laser treatment. Armed with that information, lasers can be calibrated to the proper parameters to ensure safe and successful treatments. The device factors in skin tone, melanin levels, and sun exposure to make a determination of skin type and thereby minimizing the risk for complications and improving the efficacy of the treatments.

Finally, a new anti-acne pill is said to eliminate the need for eating fatty foods to improve its absorption by the body. The pill is available by prescription only and is best suited to mitigate symptoms of extreme acne.

Im glad to see that the article made note of that the anti-acne pill may have significant side effects, says Dr. Ourian. Its important for patients to know these risks before they start any drug regimen.

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about new anti-aging treatments can be found on Epiones website.

Grace Russell Epione Medical Corporation (888) 951-3377 Email Information

Link:
Beauty Innovations – The Latest Anti-Aging Procedures

Ed Park explains aging - iHealthTube1
Dr. Park was Interviewed by iHealthTube #39;s Scott Peters at the 2012 A4M (American Academy of Anti-aging Medicine) Conference in Las Vegas. This is #1 of 10 se...

By: Ed Park

See the original post here:
Ed Park explains aging - iHealthTube1 - Video

A recent article in New Beauty magazine highlights several recently introduced anti-aging innovations. Dr. Simon Ourian of Epione Beverly Hills says hed like to see more data showing the effectiveness of these devices.

Los Angeles, California (PRWEB) April 09, 2013

I like to think that I work on the cutting edge of aesthetic medicine, but in truth I will always wait for sufficient data to be collected before I introduce new devices or products to my patients, says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. The innovations discussed in the article are interesting but Im not ready to add them to my practice just yet.

Until now, dermal fillers have only been administered with needle injections. According to the manufacturers of a new device this makes the patient more susceptible to swelling and bruising. Using pressure driven by CO2 this device allows the doctor to easily control the flow of the treatment and more accurately place fillers.

Another new device on the market allows doctors to determine a patients skin type in order to gauge how they will respond to laser treatment. Armed with that information, lasers can be calibrated to the proper parameters to ensure safe and successful treatments. The device factors in skin tone, melanin levels, and sun exposure to make a determination of skin type and thereby minimizing the risk for complications and improving the efficacy of the treatments.

Finally, a new anti-acne pill is said to eliminate the need for eating fatty foods to improve its absorption by the body. The pill is available by prescription only and is best suited to mitigate symptoms of extreme acne.

Im glad to see that the article made note of that the anti-acne pill may have significant side effects, says Dr. Ourian. Its important for patients to know these risks before they start any drug regimen.

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about new anti-aging treatments can be found on Epiones website.

Grace Russell Epione Medical Corporation (888) 951-3377 Email Information

Follow this link:
Beauty Innovations – The Latest Anti-Aging Procedures

Age Rejuvenation Centers - The Future of Healthcare | Look and Feel 20 years younger
http://www.Agerejuvenationcenters.com Age Rejuvenation Center "Do you feel sluggish or tired? Are you overweight? Are you living life to the fullest? Hormone Replac...

By: AgeRejuvenationCtrs

Go here to see the original:
Age Rejuvenation Centers - The Future of Healthcare | Look and Feel 20 years younger - Video

Bayer AG ( BAYRY ) recently presented positive results on ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC) 2013. ATX-101 is being developed for the reduction of unwanted fat deposits under the chin- submental fat (SMF).

Results from a phase IIa study showed that ATX-101 significantly and consistently reduces SMF. The level of SMF reduction was sustained in more than 90% patients who responded to treatment. Moreover, treatment satisfaction was sustained in more than 80% of these patients.

Results from another phase I pharmaco-kinetic study showed that the permanent destruction of fat cells (adipocytolysis) made by ATX-101 did not have any clinically significant impact on the serum lipid levels of the patients in the study. Notably, ATX-101 is the first injectable candidate being evaluated as a non-surgical treatment for SMF reduction in a comprehensive clinical trial setting.

In Feb 2013, Bayer presented positive results from two European phase III studies on ATX-101 at the International Master Course on Aging Skin (IMCAS). Results from the studies showed that ATX-101 reduced SMF more than placebo. ATX-101 demonstrated significant improvement in clinician-reported measurements of SMF, supported by objective caliper measurements of SMF thickness, in comparison to placebo.

Results also revealed that patients were more satisfied with their chin appearance and their treatment with ATX-101 than placebo. The candidate was well tolerated in both the studies.

We note that the studies are part of the ATX-101 clinical development program which is being conducted jointly by Bayer and Kythera Biopharmaceuticals Inc. ( KYTH ) since 2010. As per the 2010 licensing deal between the companies, Bayer acquired rights to ATX-101 in markets outside the US and Canada.

Kythera is eligible to receive tiered double-digit royalties on the sales of the drug made by Bayer outside the US and Canada. Kythera and Bayer have however collaborated to develop ATX-101 in Europe.

In Nov 2012, Kythera had reported positive interim results from a multicenter, open-label, long-term study on ATX-101. The study revealed that the candidate was well tolerated and demonstrated a similar safety profile to that observed in previous studies conducted with the candidate.

We note that Bayer suffered a huge setback last month when the company and its partner Johnson & Johnson ( JNJ ) received a second complete response letter (CRL) from the US Food and Drug Administration (FDA) for their supplemental New Drug Application (sNDA) for Xarelto (2.5 mg twice daily) for the reduction of the risk of secondary cardiovascular events in patients suffering from ACS.

The second CRL for Xarelto is a big disappointment for the company. Bayer carries a Zacks Rank #4 (Sell). The setback regarding Xarelto is primarily responsible for the bearish rank carried by the company. Cytokinetics Inc. ( CYTK ) currently looks better positioned in the pharma space carrying a Zacks Rank #1 (Strong Buy).

See the article here:
Data Presented on Bayer's ATX-101 - Analyst Blog

MONTE CARLO, Monaco--(BUSINESS WIRE)--

KYTHERA Biopharmaceuticals, Inc. (KYTH) today announced positive interim results from a Phase IIIb, multicenter, open-label study (ATX-101-11-26) of ATX-101 during the Innovations and Renewals session of the 11th Anti-Aging Medicine World Congress (AMWC), April 4-6, Monte Carlo, Monaco. The study, presented by investigator Susan Weinkle, MD, FAAD, evaluated the safety and efficacy of ATX-101, a potential first-in-class, non-surgical, injectable drug in Phase III trials for the reduction of unwanted submental fat (SMF), commonly known as double chin. The results found that ATX-101 is well tolerated and may be effective in reducing SMF by both clinician- and patient-reported outcome measures. AMWC is the worlds largest event for global aging management, and attracts aesthetic dermatologists, surgeons and clinicians in the regenerative, preventative and anti-aging medicine industry from more than 95 countries.

The positive interim results are consistent with previous ATX-101 studies, said Weinkle, a board certified dermatologist and affiliate clinical professor at the University of South Florida, Tampa, Fla., U.S. Worldwide, doctors are receiving requests from their patients for a non-surgical way to treat their double chin. The results of this study suggest that microinjections of ATX-101 have an acceptable safety profile and can reduce the appearance of a double chin with high patient satisfaction.

ATX-101 is a proprietary formulation of synthetically-derived deoxycholic acid (DCA), a molecule found in the body that helps break down dietary fat. In this open-label Phase IIIb study, interim results three months after the last ATX-101 treatment are outlined below. Observations were made using validated rating instruments for which one-grade changes are considered to be clinically meaningful:

As previously announced, 71.3 percent of subjects had at least a one-grade improvement on the CR-SMFRS / PR-SMFRS composite and 14.0 percent had at least a two-grade improvement on the same composite measure.

These results are based on a multicenter, 12-month, open-label, Phase IIIb study conducted at 21 sites across the U.S., evaluating 165 adults who received injections of ATX-101 for up to six treatments at four-week intervals. Patients received ATX-101 (2 mg/cm2) by subcutaneous microinjections directly into their SMF, and were evaluated three months after their last treatment. The study population includes females (77.6 percent) and males (22.4 percent) with a mean age of 47, who report at least moderate SMF and dissatisfaction with the appearance of their chin. All Fitzpatrick Skin Types are represented.

We are encouraged by the interim Phase IIIb results of ATX-101, said Frederick Beddingfield, III, M.D., Ph.D., KYTHERAs chief medical officer. The results, along with additional data from our ATX-101 clinical development program, support the potential for ATX-101 to enter the market as the only U.S. Food and Drug Administration (FDA)-approved drug for the reduction of double chin.

ATX-101 is the first pharmacological treatment for the reduction of submental fat to be investigated under a rigorous clinical development program with the goal of seeking regulatory approvals worldwide, specifically in the U.S., Canada and Europe. When injected, ATX-101 targets the fat cells, or adipocytes, and destroys and eliminates them.

The ATX-101 global clinical development program has enrolled more than 2,500 total patients, of which more than 1,500 have been treated with ATX-101.

About ATX-101

Link:
KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the ...

Guy DaSilva, MD, ABAARM, will be giving a pre-conference workshop on IV nutrition at the 21st Annual World Congress in Anti-Aging and Regenerative Medicine hosted by the American Academy of Anti-Aging Medicine (A4M) on April 11, 2013 in Orlando, Florida.

Sarasota, Florida (PRWEB) April 06, 2013

DaSilvas workshop, The Nuts and Bolts of Traditional IV Therapy, will teach attendees how to integrate and market IV therapies while acquiring specific protocols for chelation, nutrient depletion, fatigue, and other conditions. This will be DaSilvas third presentation of his IV nutrition workshop, which is growing in popularity since its introduction last year.

2012 attendee Dr. Burton Goldberg, an expert in alternative medicine and renowned author in alternative cancer therapies, described the workshop as vital and informative and something every doctor could utilize to become more efficient in the regeneration of the body by feeding the body what the body is screaming for.

2012 attendee Vernon Williams, MD said, The IV nutrition seminar was very helpful. It provided in-depth information on IV nutrition. We were able to incorporate it into our wellness/age management practice. The patients are very appreciative and have been getting us referrals. My office manager will be attending the seminar in Orlando.

Registration Information

Full details on the event, including registration, are available at http://www.a4m.com or by calling 888-997-0112.

About Guy DaSilva, MD, ABAARM

Dr. Guy DaSilva is the founder and medical director of the DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine in Sarasota, Florida, specializing in therapies that naturally reverse disease, restore optimal health, and prevent the destructive process of aging, including nutritional IV therapies that treat a vast array of medical conditions. He is a respected authority in hematology, pathology, internal medicine, and molecular oncology. He is considered an expert in the field of IV nutrition, and has been asked to speak around the country on this topic.

Contact: Dr. Guy DaSilva

Excerpt from:
Guy DaSilva, MD To Give Workshop On IV Nutrition At Anti - Aging Conference In Orlando, Florida

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data and daily updates provided by Morningstar, Inc.

Yahoo! - ABC News Network

See the original post:
iovera Introduced in Europe as the World's First Toxin-Free Treatment for Dynamic Facial Lines

TORONTO, ONTARIO--(Marketwired - Apr 3, 2013) - Biologix Hair Inc. (BLGX) (BLGX) announces that senior executives from the Company's clinician licensing department will be exhibiting the Biologix Hair Therapy System to attendees at the Anti-Aging World Congress, Grimaldi Forum, being held in Monte Carlo, Monaco from April 4 - 6, 2013.

Ron Holland, Biologix Hair Inc. CEO, commented, "The Anti-Aging Medicine World Congress is the world's leading conference in the fields of aesthetic and anti-aging medicine. More than 8,000 professionals from over 95 countries will be in attendance discussing topical issues and medical advances. This is an excellent opportunity for Biologix to showcase its breakthrough hair loss solution to the leading edge of opinion makers within the international medical community.

"We are determined to be in a ready position to capitalize on the high-margin sales potential of the Biologix Hair Therapy System, if and when FDA and other major market approvals are forthcoming. Exhibiting at conferences such as the Annual Anti-Aging Medicine World Congress is expected to greatly assist Biologix in rapidly expanding its global distribution network of licensed clinicians and medical practitioners seeking to become Certified Biologix Hair Therapists and secure exclusive territorial purchasing and treatment rights for the Biologix Hair Therapy System."

Biologix extends an open invitation to all attendees to visit the Biologix exhibit booth to learn more about the Biologix Hair Therapy System and how it can complement your current services and business revenues.

For more information about the Annual Anti-Aging Medicine World Congress being held this week in Monaco, visit http://www.GrimaldiForum.com.

About Biologix Hair Inc. and Biologix Hair Science Ltd.

Biologix Hair Inc. (Biologix Hair), together with its wholly owned biotechnology subsidiary, Biologix Hair Science Ltd. (BHS), is focused on realizing the full market potential for its patent-pending hair loss prevention and regeneration treatment - the Biologix Hair Therapy System - and its demonstrated ability to prevent and reverse the effects of alopecia, which plagues hundreds of millions worldwide.

Between mid-2004 and mid-2012, more than 30,000 pre-clinical-trial treatments of Biologix Revive - the essence of the Biologix Hair Therapy System - were administered to 5,000-plus patients in South America suffering with varying degrees of alopecia, as well as people seeking preventive treatment. The participating treatment clinicians subjectively observed and reported that virtually 100% of preventive care clients continued to retain their healthy hair and an estimated 80-85% of the males and 90-plus% of the females treated for hair regeneration experienced significant regrowth of their own natural hair. And among alopecia areata patients, virtually total hair regrowth was observed in 100% of the cases. To date, no negative side effects have been reported.

BHS is currently focused on obtaining FDA approval for its breakthrough hair loss prevention and regeneration therapy and has initiated a research and development program with one of the world's leading medical research universities, the Beijing Institute of Technology (BIT). The R&D program, expected to take approximately twelve months to complete, is an important final step before formal clinical trials and the FDA approval process begins.

Additionally, on May 11, 2012, Venable LLP, the Washington-based law firm overseeing the worldwide IP and regulatory approval processes on behalf of BHS, filed a Patent Cooperation Treaty (PCT) application on behalf of BHS for Biologix Revive in Geneva, Switzerland. The PCT is an international treaty, administered by the World Intellectual Property Organization (WIPO), to which 144 countries have as of now contracted, including Canada and the United States.

Read more:
Biologix Hair to Exhibit at the 11th Annual Anti - Aging Medicine World Congress, Grimaldi Forum, Monaco

Healthcare IT Live! #18 w/ Dr. Ignacio Valdes
VistA Implementer, Astronaut, LLC. http://astronautvista.com/ #65279;

By: Tim Cook

Read the original post:
Healthcare IT Live! #18 w/ Dr. Ignacio Valdes - Video

Dr. Beilin, Vice President of the Federation of Aesthetic Medicine and Anti-Aging (Fdration Syndicale des Mdecines Esthtiques et Anti-Age), will present her findings with Hybrid Energy Technology, an emerging advancement in fractional radio frequency technology that works with the bodys natural mechanisms to deliver natural volume refilling, wrinkle reduction, skin rejuvenation and acne scars treatment without surgery, discomfort or downtime.

(PRWEB) April 02, 2013

Hybrid Energy Technology, was specifically developed to work with the bodys natural mechanism to promote wrinkle reduction, skin volumizing and acne scars improvement without the need for surgery. Treatment is virtually painless and suitable for all skin types and colors. Hybrid Energy treatments deliver significant dermal enhancement and skin renewal while minimizing the epidermal visible response so procedure can be performed in a convenient walk in-walk out session.

In a recent clinical evaluation Hybrid Energy demonstrated significant skin refilling, reduction of wrinkles as well as an improvement of skin texture, minimization of pores and volume increase.

The key advantage of Hybrid Energy (HE) Technology is the combination of Hot and Electrical Invisible Micro Ablation (IMA) which is administered via a disposable tip comprised of an array of micro pins.

Hot IMA facilitates smooth and painless penetration of the micro pins to target the mid dermis. Electrical IMA then selectively affects the target area using safe non-thermal energy. This creates direct dermis stimulation and triggers the bodys natural response mechanism in a safe process, with none to minimal pain and virtually no down time. As a result, while epidermal visible response is minimized, a significant effect is generated in the Dermis that delivers Auto-production of Hyaluronic Acid, Collagen Regeneration and Elastin Growth.

Dr. Beilin:

The new novel Hybrid Energy (HE) Technology delivers hot and electrical energies to create controlled micro ablation points penetrating up to the mid dermis. HE treatments promote a natural fractional healing process for dermal volume refilling and skin renewal. In my findings HE treatments demonstrated skin refilling effect along with improvement of skin texture and irregularities. No significant adverse effects were detected and treatments were well tolerated by patients with none to minimal pain and no down time.

Hybrid Energy Technology is available through Surgen- a cutting-edge platform which also integrates TriFractional Technology - an advanced anti-aging 3 pulse radio frequency procedure that enables effective fractional skin resurfacing and is suitable for enhancing the Hybrid Energy treatment. The Surgen platform has a user friendly touch screen with pre-programmed but adjustable parameters for each treatment type.

Mr. Amichai Bar-Nir CEO of Pollogen: We are very excited that the distinguished Dr. Beilin will be presenting Hybrid Energy at the Anti-Aging Conference in Monte Carlo. Pollogen is continuously listening to the demands of the market to deliver solutions for superior aesthetic results. The innovative Hybrid Energy Technology with Hot and Electrical Invisible Micro Ablation, provides a breakthrough answer for volume refilling, wrinkle reduction and skin rejuvenation all with a simple, virtually painless walk in walk out procedure. We are confident that it will quickly become an industry gold standard.

See the original post:
Dr. Ghislaine Beilin to Present Hybrid Energy Technology at the Upcoming Anti - Aging Medicine Congress in Monte Carlo

Ed Park on telomere length - iHealthTube3
Dr. Park was Interviewed by iHealthTube #39;s Scott Peters at the 2012 A4M (American Academy of Anti-aging Medicine) Conference in Las Vegas. This is #3 of 10 se...

By: Ed Park

Original post:
Ed Park on telomere length - iHealthTube3 - Video